SGX Nifty gains, pharma stocks in focus
- IPL spot-fixing case: Net widens, police watching 3 more players, other bookies
- IPL 2013: Imperious Brad Hodge powers Rajasthan Royals to qualifier
- Sonia Gandhi, PM Manmohan Singh slam BJP for disrupting Parliament, stalling bills
- IPL spot-fixing: 'Bookie' Vindoo was close to BCCI chief's son-in-law, say cops
- Jessica Lall case: Shayan Munshi to face perjury trial
* Nifty futures on the Singapore Exchange rise 0.21 per cent. The MSCI-Asia Pacific index excluding Japan is also up 0.4 per cent.
* Asian shares ambled higher on Friday and were on course for a weekly gain of more than 2 per cent, their best in two months, after manufacturing surveys from China and the United States raised hopes that the global growth outlook is improving at last.
* Foreign investors bought Rs 1.83 billion, while Domestic institutions sold Rs 1.64 billion of stocks on Thursday when the BSE index rose 0.31 per cent.
* Pharmaceutical shares will be in focus, as India approved a new drug pricing policy designed to increase the number of drugs deemed essential that are subject to price caps, two ministers told reporters.
* India's cabinet approved on Thursday a 9.5 per cent government stake sale in state-run power producer NTPC Ltd, a minister told reporters, to help rein in its ballooning fiscal deficit.
* Investors will watch Hindustan Copper Ltd shares a day after it sets floor price for share sale at Rs 155 a share. Hindustan Copper shares closed at Rs 266.15 on Thursday.
- Fixing probe now reaches Bollywood, son of Dara Singh held
- BCCI cashes Pune Warriors guarantee, 'disgusted' Sahara walks out of IPL
- Sreesanth spent Rs 1.95L on clothes, bought friend BlackBerry, paid in cash: Police
- Delhi firm with MoD as client is linked to Pak cyberattacks
- After Infosys, iGATE sacks Phaneesh Murthy for sexual misconduct
- 2 weeks after harassment, Haryana schoolgirls return, cops in tow